GSK shares dive as weaker vaccine sales and restructuring charges unnerve investors

British pharma company reports declining profits amid concerns over looming patent loss for blockbuster HIV drug Business live – latest updates Shares in GSK slid on Wednesday despite the UK drugmaker reporting better than expected financial results, as investors were unnerved by weaker vaccine sales, restructuring charges and its overall outlook.

Britain’s second-biggest pharmaceutical company reported a 19%…